Main Article Content
Introduction: End Stage renal disease (ESRD) is an irreversible progressive condition responsible for high morbidity and mortality. Long term treatment and lifestyle modifications are difficult to adapt which significantly impairs treatment adherence and quality of life.
Aim: To assess the treatment adherence of ESRD patients undergoing maintenance hemodialysis. Methodology: A prospective, observational, comparative, multicentre study was done for 10 months. Demographic and clinical parameters were collected from medical records and their treatment adherence was assessed using End-Stage Renal Disease-Adherence Questionnaire (ESRD-AQ). The responses were scored and identified the patients having low adherence.
Results: A total of 121 patients were enrolled in the study with a mean age of 62.14± 11.41 years. Dietary adherence and fluid restriction were observed at 63.33% and 60.33% respectively. Adherence to hemodialysis sessions indicated 97% while towards medication was 67.77%. A significant correlation existed between clinical biomarkers with specific adherence scores which suggest the validity of reported adherence scores. Awareness of patients regarding the diet, fluids, and, medications through patient counselling was found to be very effective in improving the adherence in ESRD populations.
Conclusion: The study concludes that a huge number of hemodialysis patients are non-adherent to the treatment and the pharmacist role is pivotal in improving treatment adherence and patient compliance.
Thomas R, Kanso A, Sedor JR. Chronic Kidney Disease and Its Complications. Prim Care. 2008;35(2):329–vii.
Loghman-Adham M. Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation. Am J Manag Care. 2003;9(2):155-171.
Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009; 75(11):1223-1229.
Shao DR, Zhou Y. Efficacy of dialysis for the treatment of patients with diabetic nephropathy: Study protocol. Medicine (Baltimore). 2019;98(47):e17923.
Naalweh KS, Barakat MA, Sweileh MW, Al-Jabi SW, Sweileh WM, Zyoud SH. Treatment adherence and perception in patients on maintenance hemodialysis: a cross – sectional study from Palestine. BMC Nephrology. Springer Science and Business Media LLC; 2017;18(1).
Ghimire S, Castelino RL, Lioufas NM, Peterson GM, Zaidi STR. Nonadherence to Medication Therapy in Haemodialysis Patients: A Systematic Review. Chilcot J, editor. PLOS ONE. Public Library of Science (PLoS). 2015;10(12):e0144119.
Leggat JE Jr, Orzol SM, Hulbert-Shearon TE, et al. Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis. 1998;32(1):139-145.
Umeukeje EM, Mixon AS, Cavanaugh KL. Phosphate-control adherence in hemodialysis patients: current perspectives. Patient Prefer Adherence. 2018;12:1175-1191.
Mukakarangwa MC, Chironda G, Bhengu B, Katende G. Adherence to Hemodialysis and Associated Factors among End Stage Renal Disease Patients at Selected Nephrology Units in Rwanda: A Descriptive Cross-Sectional Study. Nurs Res Pract. 2018;2018:4372716.
Schmid H, Hartmann B, Schiffl H. Adherence to prescribed oral medication in adult patients undergoing chronic hemodialysis: a critical review of the literature. Eur J Med Res. 2009;14(5):185-190.
Chan KE, Thadhani RI, Maddux FW. Adherence barriers to chronic dialysis in the United States. J Am Soc Nephrol. 2014;25(11):2642-2648.
Karamanidou C, Clatworthy J, Weinman J, Horne R. A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol. 2008;9:2.